Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Orthocell Ltd ( (AU:OCC) ) is now available.
Orthocell Ltd has announced a proposed issue of 2,000,000 options expiring on August 31, 2028, with an exercise price of $1.53. This move is part of a placement or other type of issue, aimed at potentially enhancing the company’s financial position and supporting its strategic initiatives in the regenerative medicine market.
The most recent analyst rating on (AU:OCC) stock is a Buy with a A$1.32 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd is a company operating in the biotechnology sector, focusing on the development and commercialization of regenerative medicine products. The company primarily specializes in innovative treatments for the repair and regeneration of soft tissue injuries, catering to a significant market need in the healthcare industry.
Average Trading Volume: 926,850
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$336.6M
For an in-depth examination of OCC stock, go to TipRanks’ Overview page.